Clinical trialNARecruiting
The Use of Contrast Enhanced Ultrasound (CEUS) In Post-Surgical Pancreatic Cancer Patients to Evaluate Local Disease Recurrence
The Use of Contrast Enhanced Ultrasound (CEUS) In Post-Surgical Pancreatic Cancer Patients to Evaluate Local Disease Recurrence- A Feasibility Study
- Outcome
- Ongoing
- Phase
- NA
- Status
- Recruiting
- Study type
- Interventional
- Start
- 29 July 2026
- Expected end
- December 2026
- Enrollment
- 10 participants
- Sites
- 1
- Primary outcomes
- Presence of Contrast Enhancement in the Pancreatic Surgical Site on CEUS
- Sponsor
- Other
- Results posted
- No
- Last update
- 2 November 2026
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try